CZMGX vs. ECAT

Last updated Jun 6, 2026

CZMGX (Multi-Manager Growth Strategies Fund) and ECAT (BlackRock ESG Capital Allocation Term Trust) are both mutual funds - CZMGX is a Large Cap Growth Equities fund managed by BlackRock, while ECAT is a Derivative Income fund managed by BlackRock. Over the past 3 years, CZMGX returned 24.62%/yr vs 18.45%/yr for ECAT. A 0.70 correlation means they provide meaningful diversification when combined. CZMGX charges 0.74%/yr vs 1.38%/yr for ECAT.

Performance

CZMGX vs. ECAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Multi-Manager Growth Strategies Fund (CZMGX) and BlackRock ESG Capital Allocation Term Trust (ECAT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both investments are quite close, with CZMGX having a 9.32% return and ECAT slightly higher at 9.37%.

CZMGX

• 1D: 0.09%
• 1M: 3.65%
• YTD: 9.32%
• 6M: 8.24%
• 1Y: 24.55%
• 3Y*: 24.62%
• 5Y*: 13.66%
• 10Y*: —

ECAT

• 1D: -1.85%
• 1M: 4.09%
• YTD: 9.37%
• 6M: 8.16%
• 1Y: 18.37%
• 3Y*: 18.45%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CZMGX vs. ECAT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CZMGX Multi-Manager Growth Strategies Fund	9.32%	15.18%	34.55%	41.78%	-29.41%	6.46%
ECAT BlackRock ESG Capital Allocation Term Trust	9.37%	16.64%	19.96%	32.36%	-21.90%	-6.25%

Correlation

The correlation between CZMGX and ECAT is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.60
Correlation (3Y) Calculated over the trailing 3-year period	0.65
Correlation (All Time) Calculated using the full available price history since Sep 29, 2021	0.70

The correlation between CZMGX and ECAT has been stable across timeframes, ranging from 0.60 to 0.70 - a consistent structural relationship.

Return for Risk

CZMGX vs. ECAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CZMGX

CZMGX Risk / Return Rank: 25
CZMGX Sharpe Ratio Rank: 31
CZMGX Sortino Ratio Rank: 28
CZMGX Omega Ratio Rank: 29
CZMGX Calmar Ratio Rank: 18
CZMGX Martin Ratio Rank: 19

ECAT

ECAT Risk / Return Rank: 24
ECAT Sharpe Ratio Rank: 25
ECAT Sortino Ratio Rank: 23
ECAT Omega Ratio Rank: 24
ECAT Calmar Ratio Rank: 21
ECAT Martin Ratio Rank: 25

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CZMGX vs. ECAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Multi-Manager Growth Strategies Fund (CZMGX) and BlackRock ESG Capital Allocation Term Trust (ECAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CZMGX	ECAT	Difference
Sharpe ratio: Return per unit of total volatility	1.51	1.36	+0.15
Sortino ratio: Return per unit of downside risk	2.10	1.95	+0.15
Omega ratio: Gain probability vs. loss probability	1.27	1.24	+0.02
Calmar ratio: Return relative to maximum drawdown	1.44	1.56	-0.13
Martin ratio: Return relative to average drawdown	4.68	5.86	-1.18
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CZMGX vs. ECAT - Sharpe Ratio Comparison

The current CZMGX Sharpe Ratio is 1.51, which is comparable to the ECAT Sharpe Ratio of 1.36. The chart below compares the historical Sharpe Ratios of CZMGX and ECAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CZMGX	ECAT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.51	1.36	+0.15
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.64	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.73	0.52	+0.21

Drawdowns

CZMGX vs. ECAT - Drawdown Comparison

The maximum CZMGX drawdown since its inception was -35.23%, which is greater than ECAT's maximum drawdown of -32.23%. Use the drawdown chart below to compare losses from any high point for CZMGX and ECAT.

Drawdown Indicators

	CZMGX	ECAT	Difference
Max Drawdown Largest peak-to-trough decline	-35.23%	-32.23%	-3.00%
Max Drawdown (1Y) Largest decline over 1 year	-16.55%	-11.80%	-4.75%
Max Drawdown (3Y) Largest decline over 3 years	-22.71%	-15.79%	-6.92%
Max Drawdown (5Y) Largest decline over 5 years	-35.23%	—	—
Current Drawdown Current decline from peak	-0.86%	-2.85%	+1.99%
Average Drawdown Average peak-to-trough decline	-7.58%	-9.10%	+1.52%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.07%	3.14%	+1.93%

Volatility

CZMGX vs. ECAT - Volatility Comparison

The current volatility for Multi-Manager Growth Strategies Fund (CZMGX) is 3.58%, while BlackRock ESG Capital Allocation Term Trust (ECAT) has a volatility of 3.95%. This indicates that CZMGX experiences smaller price fluctuations and is considered to be less risky than ECAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CZMGX	ECAT	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.58%	3.95%	-0.37%
Volatility (6M) Calculated over the trailing 6-month period	11.82%	10.65%	+1.17%
Volatility (1Y) Calculated over the trailing 1-year period	15.71%	13.56%	+2.15%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.52%	16.90%	+4.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.83%	16.90%	+4.93%

CZMGX vs. ECAT - Expense Ratio Comparison

CZMGX has a 0.74% expense ratio, which is lower than ECAT's 1.38% expense ratio.

Dividends

CZMGX vs. ECAT - Dividend Comparison

CZMGX has not paid dividends to shareholders, while ECAT's dividend yield for the trailing twelve months is around 22.08%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
CZMGX Multi-Manager Growth Strategies Fund	0.00%	11.02%	10.86%	5.59%	10.39%	15.19%	5.04%	5.53%	6.87%	4.66%
ECAT BlackRock ESG Capital Allocation Term Trust	22.08%	23.00%	17.44%	9.14%	8.94%	0.54%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CZMGX and ECAT in my portfolio?

CZMGX and ECAT have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CZMGX or ECAT?

ECAT has higher volatility (3.95%) compared to CZMGX (3.58%). In terms of maximum drawdown, CZMGX dropped -35.23% vs ECAT's -32.23%.

Which has better risk-adjusted returns?

CZMGX currently has the higher Sharpe Ratio (1.51 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.